Access to clinical trials is an important aspect of cancer care. St. John's Mercy David C. Pratt Cancer Center is committed to offering a variety of opportunities for patients to participate in research studies. The Department of Oncology Research provides clinical and administrative support for clinical trials within the David C. Pratt Cancer Center. Medical oncologists, radiation oncologists and surgical specialists work together to provide the latest innovations in cancer care to our patients.

Phase II, III, and IV trials in prevention, treatment and supportive care are available for many types of cancer. More than 50 National Cancer Institute (NCI) trials are available through the St. Louis-Cape Girardeau Community Clinical Oncology Program, a consortium of five regional hospitals headquartered at St. John's Mercy.

The University of Chicago Phase II Consortium is designed to offer investigational novel agents to patients from states in the Midwest. David C. Pratt Cancer Center is the only institution in the St. Louis area participating in this consortium. This affiliation complements our current clinical trial offerings from other NCI groups as well as our studies sponsored by pharmaceutical companies.